Type:Notice
Citation:90 FR 2008
Reading Time:about 3 minutes
The Food and Drug Administration (FDA) has renewed the charter for the Antimicrobial Drugs Advisory Committee until October 7, 2026. This independent advisory group helps the FDA ensure that drugs used to treat infectious diseases are safe and effective. The committee includes 13 voting members with expertise in fields like infectious diseases and internal medicine. The renewal is considered important to support public interest and ensure continued expert advice on drug safety and effectiveness.
Simple Explanation
The FDA is keeping a special group of experts, called the Antimicrobial Drugs Advisory Committee, to help make sure that medicines for infections are safe and work well, and this group will continue to do their job until 2026.